Evidence map›Paper›PMID 38025285›Full record

ArticlePerspectives in clinical research

Characteristics, attitudes, and the odds for positive attitude toward clinical trial: A study on Indonesian COVID-19 vaccine trial participants.

Nani Maharani, Nuvi Gustriawanto, Yetty M Nency, Endang Mahati, Glenn F Yeremia, Dimas T Anantyo, Rebriarina Hapsari, Mulyono Mulyono, Setyo G Pramudo, Nur Farhanah

Open access · diamondAbstract read
In one paragraph

Article in Perspectives in clinical research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 82% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Nani MaharaniDepartment of Pharmacology and Therapy, Universitas Diponegoro, Semarang, Indonesia.
Nuvi GustriawantoCOVID 19 Vaccine Bio Farma - Universitas Diponegoro (COBIU) Study, Universitas Diponegoro, Semarang, Indonesia.
Yetty M NencyDepartment of Child Health, Faculty of Medicine, Universitas Diponegoro, Semarang, Indonesia.
Endang MahatiDepartment of Pharmacology and Therapy, Universitas Diponegoro, Semarang, Indonesia.
Glenn F YeremiaCOVID 19 Vaccine Bio Farma - Universitas Diponegoro (COBIU) Study, Universitas Diponegoro, Semarang, Indonesia.
Dimas T AnantyoDepartment of Child Health, Faculty of Medicine, Universitas Diponegoro, Semarang, Indonesia.
Rebriarina HapsariDepartment of Microbiology, Faculty of Medicine, Universitas Diponegoro, Semarang, Indonesia.
Mulyono MulyonoDepartment of Child Health, Faculty of Medicine, Universitas Diponegoro, Semarang, Indonesia.
Setyo G PramudoDepartment of Internal Medicine, Faculty of Medicine, Universitas Diponegoro, Semarang, Indonesia.
Nur FarhanahDepartment of Internal Medicine, Faculty of Medicine, Universitas Diponegoro, Semarang, Indonesia.
Diponegoro University · ID

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aims: This study was performed to understand the Indonesian population's characteristics and the factors that contribute to a more positive attitude toward participation in a clinical trial. Methods: A cross-sectional survey was conducted involving 402 COVID-19 vaccine trial participants in Semarang, Indonesia, utilizing self-reporting questionnaires consisting of questions related to socio-demographic characteristics and statements in a 5-scaled Likert Scale to assess the attitude toward vaccine trial. The odds for positive attitude were analyzed using Ordinal Logistic Regression to obtain the odd-ratio and 95% confidence interval. The Results: Most of the respondents were adults aged 22-64-year-old (89.30%), males (63.68%), married (77.61%), worked as an employee (59.70%), obtained information about the clinical trial from the Public Health Service (41.29%), had a low education level (40.80%), a low monthly income level (68.41%), with no previous participation in a clinical trial (90.80%). All respondents showed a good attitude toward the trial, with low education level, nonemployment status, fewer or no previous participation in clinical trials, and getting the information from the public health centers were the main predictors for better attitude toward vaccine trials. Conclusion: There was a positive attitude toward vaccine trials in the Indonesian population. The positive attitude could be driven by having a low education level, nonemployment status, fewer or no previous participation in the clinical trial, and getting information from public health centers.

Indexed as

Motivationsperceptionspositive attitudevaccine clinical trial

Identifiers

PMID38025285
PMCPMC10679572
OpenAlexW4387414463

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.